More than 190 countries, a treaty approve of trying to better face the next pandemic

More than 190 countries have succeeded in taking on the first global treaty on pandemies in history in the context of negotiations in the World Health Organization (WHO) and after three years of heavy deliberations.

This international agreement will help better coordination between countries and a more fair distribution of the available resources to see the following pandemic, which scientists agree that sooner or later it will take place with some new pathogen.

The agreement offers the most important guidelines for national and international level to develop prevention, preparation and response mechanisms for future pandemies, with an emphasis on aspects such as solidarity and reciprocity, although not to the extent that countries with average and low developing countries would be expected.

Various diplomats who participated in the last part of the negotiations, including marathons sessions for up to 24 hours, regretted Much of the obligations accepted in the agreement of volunteerBut they explained that they were before the dilemma of “accepting what is on the table or becomes empty.”

Moreover, these negotiations have been seen as an opportunity to show international unity and support for multilateralism at a time when who is confronted with one of the most difficult moments of his 75 years of his existence for the retirement of the United States and the loss of considerable resources that this country labeled.

The agreement creates a global network for delivery and logistics to try to guarantee fair, fast and affordable access to products (medicines, vaccines, medical material, among other things), not only to face and control a pandemic, but also necessary in situations of humanitarian crises.

The aim is that there is transparency in that chain and coordinates existing international reserves, which are supplemented with another article, in which countries are not allowed to make “excessive national reserves” of vital products to stop a pandemic.

Similarly, the treaty determines a new access and participation mechanism in the benefits obtained of shared pathogens in an existing system and that manages who.

The big change to achieve with regard to the situation that prevails during the Pandemie is that pharmacists who gain access to these pathogens, from which vaccines and treatments can be examined and developed, assign 20 % of the product that the WHO produces, half as donation and the rest at an affordable price, so that the organization is more urgent.

When the last pandemic broke out, various governments of developed countries financed the pharmaceutical and biotechnology industry to speed up the development of a vaccine and treatment, but there was no return of that investment and, as soon as the vaccine was ready, they had to negotiate their acquisition with the producing signatures.

The agreement reached is intended to prevent something like that and for this it indicates for the first time that the financing of the research and the development of new treatments, diagnoses or vaccines with public funds must be done in circumstances that guarantee a benefit for the public interest.